Task: Answer the multiple-choice question.
Question: Which drug exhibits a 14.726% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) CCCn1c(SCC(N)=O)nnc1C(C)C
(b) COc1cccc(C(=O)Nc2ccc3c(c2)n(C)c(=O)n3C)c1
(c) Cc1oc(-c2cc(Cl)cc(Cl)c2)cc1C(=O)NCCc1ccccc1
Answer: a. CCCn1c(SCC(N)=O)nnc1C(C)C
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1c(SCC(N)=O)nnc1C(C)C
CCCn1c(SCC(N)=O)nnc1C(C)C
2-[(5-propan-2-yl-4-propyl-1,2,4-triazol-3-yl)sulfanyl]acetamide